Thats not even the biggest point. Missing the forest for the trees.
It allows insurers to establish “criteria” in order to limit availability of high cost drugs and therapies. A key factor is in a scale prepared by the American Enterprise Institute, which helped Ryan prepare the plan. This scale creates a “benefit/survivability factor” which will allow certain treatments to be denied based on age and economic factors.
Using the plan, a 70 year old with stage 2 cancer with a fixed income of over $75,000 per year will be considered “more survivable” than someone at a lower income level and qualify for high cost targeted therapies now making huge inroads against cancer. The poor and even the typical middle class will simply be told, “We’re sorry, there isn’t anything we can do but make you as comfortable as possible.”
Thats probably why they expect premiums to decrease 10% over time ( and we know that won't happen)